A Therapeutic Whole-Tumor-Cell Vaccine Covalently Conjugated with a TLR7 Agonist

A single-protein or -peptide vaccine is not sufficient to arouse immune responses in cancer therapy. A whole-tumor-cell vaccine with complete cancer cell antigens and all conformations elicits robust immune responses and is a promising method for the treatment of advanced malignant tumors. In this s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Huju, Hao, Yue, Wang, Xia, Tang, Li, Deng, Yongqiang, Chen, Xianxiong, Gao, Feng, Sha, Ou, Jin, Guangyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266217/
https://www.ncbi.nlm.nih.gov/pubmed/35805071
http://dx.doi.org/10.3390/cells11131986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266217/
https://www.ncbi.nlm.nih.gov/pubmed/35805071
http://dx.doi.org/10.3390/cells11131986

Ejemplares similares